MinJaniceLuMD

Oncology • Chicago, IL

Hematologic Oncology

Physician

Join to view full profile

Dr. Lu is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Lu's full profile

Already have an account?

Office
250 E Superior St
Ste 4-420
Chicago, IL 60611
Phone+1 312-695-0990

Fax+1 312-472-4784

Education & Training

NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 2002 - 2003
NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 2000 - 2002
St Joseph's University Medical CenterResidency, Internal Medicine, 1997 - 2000
Beijing Medical UniversityClass of 1995

Certifications & Licensure

IL State Medical License 2023 - 2026
CA State Medical License 2014 - 2025
NY State Medical License 2000 - 2015
NJ State Medical License 2003 - 2005
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

12 citations
CXCL8/CXCR2 signaling mediates bone marrow fibrosis and is a therapeutic target in myelofibrosis.
Andrew J Dunbar, Dongjoo Kim, Min Lu, Mirko Farina, Robert L Bowman
Blood. 2023-05-18
11 citations
Tucatinib has Selective Activity in HER2-Positive Cancers and Significant Combined Activity with Approved and Novel Breast Cancer-Targeted Therapies.
Neil A O'Brien, Holly K T Huang, Martina S J McDermott, Athena M Madrid, Tong Luo
Molecular Cancer Therapeutics. 2022-05-04
2 citations
Characterization of disease-propagating stem cells responsible for myeloproliferative neoplasm-blast phase.
Xiaoli Wang, Raajit K Rampal, Cing Siang Hu, Joseph Tripodi, Noushin Farnoud
JCI Insight. 2022-04-22

Abstracts/Posters

Expansion of Prior Existing TP53 Mutated Clones in Polycythemia Vera Patients Treated with Idasanutlin
Min Lu, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Significance of Abnormalities of PPM1D in Myeloproliferative Neoplasms
Min Lu, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

A Novel Combination of Drugs Which Target Both the Intrinsic and Extrinsic Apoptotic Pathways to Eliminate Myelofibrosis CD34+ Cells
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019